4//SEC Filing
King John C 4
Accession 0001104659-18-029858
CIK 0001481512other
Filed
May 1, 8:00 PM ET
Accepted
May 2, 4:42 PM ET
Size
7.9 KB
Accession
0001104659-18-029858
Insider Transaction Report
Form 4
King John C
Chief Commercial Officer
Transactions
- Award
Option to Purchase Common Stock
2018-05-01+190,000→ 190,000 totalExercise: $6.20Exp: 2028-05-01→ Common Stock (190,000 underlying) - Award
Restricted Stock Units
2018-05-01+45,987→ 45,987 total→ Common Stock (45,987 underlying)
Footnotes (3)
- [F1]The stock option vests as to 25% of the underlying shares on April 16, 2019 and as to the remainder of such shares in 36 substantially equal monthly installments upon the reporting person's completion of each successive month of service thereafter, such that the option will become fully vested and exercisable on April 16, 2022.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The restricted stock units vest in three substantially equal installments on each of April 16, 2019, April 16, 2020, and April 16, 2021.
Documents
Issuer
Ra Pharmaceuticals, Inc.
CIK 0001481512
Entity typeother
Related Parties
1- filerCIK 0001738190
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 4:42 PM ET
- Size
- 7.9 KB